A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04).
- DOI
- 10.1038/s41598-026-57970-9
- Published
- 2026 Jun 29
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-57970-9,
title = {A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04).},
author = {Lim AR and Kang SY and Choi MK and Lee MA and Kim JY and Koo DH and Beom SH and Hong S and Jo J and Kim JH and Lee S},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-57970-9},
url = {https://doi.org/10.1038/s41598-026-57970-9}
}RIS
TY - JOUR TI - A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04). AU - Lim AR AU - Kang SY AU - Choi MK AU - Lee MA AU - Kim JY AU - Koo DH AU - Beom SH AU - Hong S AU - Jo J AU - Kim JH AU - Lee S PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-57970-9 UR - https://doi.org/10.1038/s41598-026-57970-9 ER -
APA
AR, L., SY, K., MK, C., MA, L., JY, K., DH, K., SH, B., S, H., J, J., JH, K., & S, L. (2026). A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04).. Scientific reports. https://doi.org/10.1038/s41598-026-57970-9
Source records
- pubmed · retrieved 2026-09-26T22:48:34.158Z
- europe-pmc · retrieved 2026-09-26T22:48:34.173Z